| 12281172 |
Cross-species-specific PSMAxCD3 bispecific single chain antibody |
Peter Kufer, Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann +6 more |
2025-04-22 |
| 11987633 |
Cross-species-specific single domain bispecific single chain antibody |
Peter Kufer, Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann +2 more |
2024-05-21 |
| 11472886 |
Cross-species-specific PSMAxCD3 bispecific single chain antibody |
Peter Kufer, Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann +6 more |
2022-10-18 |
| 11154617 |
Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemia |
Patrick Baeuerle, Peter Kufer, Eugen Leo |
2021-10-26 |
| 11084876 |
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains |
Peter Kufer, Dirk Nagorsen, Juergen Scheele, Gerhard Zugmaier, Patrick Hoffmann +2 more |
2021-08-10 |
| 10981998 |
Cross-species-specific single domain bispecific single chain antibody |
Peter Kufer, Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffman +2 more |
2021-04-20 |
| 9688760 |
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains |
Peter Kufer, Dirk Nagorsen, Juergen Scheele, Gerhard Zugmaier, Patrick Hoffmann +2 more |
2017-06-27 |
| 9587036 |
Cross-species-specific PSMAxCD3 bispecific single chain antibody |
Peter Kufer, Ralf Lutterbuese, Petra Fluhr, Doris Rau, Susanne Hausmann +6 more |
2017-03-07 |
| 9486475 |
PPS for the prevention of potential adverse effects caused by CD3 specific binding domains |
Peter Kufer, Dirk Nagorsen, Juergen Scheele, Gerhard Zugmaier, Patrick Hoffmann +2 more |
2016-11-08 |
| 8007796 |
Means and methods for the treatment of tumorous diseases |
Patrick Baeuerle, Peter Kufer, Eugen Leo |
2011-08-30 |